Dr. Rajiv Kovil | Diabetes and Endocrinology | Omnicuris

Home

Courses

MedShots

Survey

Verifying...

Loading, please wait...

About Us Contact Us FAQs Privacy Policy Terms of Use ISO

Download Our Mobile App

Copyright © 2026 Omnicuris Healthcare Pvt Ltd. All rights reserved.

"Wherever the art of Medicine is loved, there is also a love of Humanity."

Hippocrates

Made with❤️byOmnicuris

© 2026 Omnicuris Healthcare Pvt Ltd.

Medshots Help Profile

Dr. Rajiv Kovil | Diabetes and Endocrinology | Omnicuris

Dr. Rajiv Kovil

Head of Diabetology & Chairman, Zandra Healthcare, Mumbai

Qualification

Diabetes and Endocrinology

Location

Mumbai City South, Maharashtra, India

Qualification

Diabetes and Endocrinology

Location

Mumbai City South, Maharashtra, India

Educational Content

13 Sessions

D1 S1 Discussion 2

D1 S1 Discussion 2

Evolving Evidence With Newer Dpp4i: Evogliptin

Evolving Evidence With Newer Dpp4i: Evogliptin

Redefining Management of T2dm

Redefining Management of T2dm

Insulin Delivery Automation to Improve Clinical Outcomes and to Reduce Patient Burden

Insulin Delivery Automation to Improve Clinical Outcomes and to Reduce Patient Burden

Realities & Real World Evidence: Clinical Relevance in the Management of Diabetes

Realities & Real World Evidence: Clinical Relevance in the Management of Diabetes

SGLT2i as First Line Therapy in T2DM? Yes / No

SGLT2i as First Line Therapy in T2DM? Yes / No

Glinides

Glinides

Diabetes Management in The age of COVID -19 With Point of Care Testing

Diabetes Management in The age of COVID -19 With Point of Care Testing

Discussion 2

Discussion 2

Time to Rewind : Extra Glycemic Benefits of Glp1 Ras

Time to Rewind : Extra Glycemic Benefits of Glp1 Ras

Essential aspects of successful insulin therapy: Dosing, titration, storage and transport

Essential aspects of successful insulin therapy: Dosing, titration, storage and transport

Early initiation of SGLT2i – Is it rewarding?

Early initiation of SGLT2i – Is it rewarding?

A New Take on Insulin Glargine

A New Take on Insulin Glargine